About this trial
The COHESION-I project will evaluate the effects of the co-creation intervention (2016 to 2019) and the co-design intervention (2023 to 2024) on improving (a) health system responsiveness, and (b) patient satisfaction, at the primary health care level, in Peru, Nepal and Mozambique, in relation to chronic diseases (hypertension, and diabetes mellitus), as well as specific neglected tropical diseases. Each intervention has been tailored to the context and characteristics of each one of the aforementioned low- and middle-income countries.
For this quasi-experimental study, three arms were established: the co-creation (2016 to 2019) + co-design (2023 to 2024) arm; the co-design only (2023 to 2024) arm; and the control group (no intervention; usual care). The evaluation will be composed of four types of evaluations: quantitative; qualitative; economic; and process evaluation
Eligibility criteria
Qualifiers
Males or females aged 18 years and over, from the selected sites
Having used the health services in the previous three months
Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis
Must be able to listen to radio programs, or other audio material
Disqualifiers
None
Trial design
Treatments tested in this trial
- Co-creation (2016 to 2019) + Co-design (2023 to 2024)
- Co-design only (2023 to 2024)
Treatment groups
Sponsors and collaborators
Universidad Peruana Cayetano Heredia
Lead sponsor
Eduardo Mondlane University
Collaborator
B.P. Koirala Institute of Health Sciences
Collaborator